MC

June 1, 2017

OBI Pharma Announces Acquisition of TH-3424 from Threshold Pharmaceuticals

[…]
January 25, 2017

China FDA approves Clinical Trial Application for Adagloxad Simolenin Phase III Study

[…]
January 20, 2017

OBI Pharma holds EOP2 meeting with US FDA

[…]
January 10, 2017

OBI Pharma Deeply Disappointed with Prosecutor’s Decision to Proceed with Cases. Facts should demonstrate Innocence.

[…]